idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
25.08.2020 11:00

Blocking cellular communication stops SARS-CoV-2 - Patent on signaling inhibitor for COVID-19 treatment

Markus Bernards Public Relations und Kommunikation
Goethe-Universität Frankfurt am Main

    FRANKFURT. Many viruses use and manipulate the communication pathways of their host cells to boost their own replication. Now, for the first time, biochemists and virologists from Goethe University and University Hospital Frankfurt have drawn a complete picture of communication within a human cell infected with SARS-CoV-2. In cell culture experiments, the researchers succeeded in stopping virus replication with a series of cancer drugs tested in clinical practice. The drugs target the places where several of the cell’s communication pathways meet (Molecular Cell, DOI 10.1016/j.molcel.2020.08.006). The scientists in Frankfurt have now filed a patent for their method.

    In the transmission of signals within the cell which, for example, stimulate cell growth or trigger metabolic processes, phosphate groups play an important biochemical role. The phosphate groups are often attached to proteins or removed to control activity. In this process, a change in the protein triggers the next one and the signal is transmitted in a signaling cascade. The target is usually the cell nucleus, where genes are switched on or off.

    For the first time, biochemists and virologists from Goethe University have now succeeded in documenting the full picture of all the communication pathways in a human cell infected with SARS-CoV-2 and observed what changes the infection triggers. To do so, they analyzed all proteins carrying a phosphate group at a given moment in time – what is known as the phosphoproteome. The result: SARS-CoV-2 evidently uses above all those signaling pathways of the host cell where a growth signal is transmitted into the cell from outside. If these signaling pathways are interrupted, the virus is no longer able to replicate.

    Dr. Christian Münch from the Institute of Biochemistry II at Goethe University explains: “The signaling pathways of the growth factors can be blocked precisely at the point where the signal from outside the cell docks onto a signal receiver – a growth factor receptor. There are, however, a number of very effective cancer drugs that interrupt growth factor signaling pathways slightly further down the cascade, through which the signals of different growth factor receptors are blocked. We’ve tested five of these substances on our cells, and all five led to a complete stop of SARS-CoV-2 replication.”

    Professor Jindrich Cinatl from the Institute of Medical Virology at University Hospital Frankfurt says: “We conducted our experiments on cultivated cells in the laboratory. This means that the results cannot be transferred to humans without further tests. However, from trials with other infectious viruses we know that viruses often alter signaling pathways in their human host cells and that this is important for virus replication. At the same time, already approved drugs have a gigantic lead in terms of development so that it would be possible – on the basis of our results and just a few more experiments – to start clinical studies very quickly.”

    Via INNOVECTIS, the researchers have patented their method of interrupting signaling pathways by means of specific inhibitors in order to treat COVID-19. INNOVECTIS was founded in 2000 as a subsidiary of Goethe University and has operated successfully since then as a service provider in the transfer of academic know-how into business practice.


    Wissenschaftliche Ansprechpartner:

    Professor Dr. rer. nat. Jindrich Cinatl
    Head of Cinatl Research Group
    Institute for Medical Virology, University Hospital Frankfurt
    Phone: +49 (0) 69 / 6301-6409
    cinatl@em.uni-frankfurt.de,

    Dr. Christian Münch
    Head of Muench Research Group
    Institute for Biochemistry II, Goethe University Frankfurt
    Phone: +49 (0) 69 6301 6599
    ch.muench@em.uni-frankfurt.de


    Originalpublikation:

    Publication: Kevin Klann, Denisa Bojkova, Georg Tascher, Sandra Ciesek, Christian Münch,
    Jindrich Cinatl. Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication. Molecular Cell, https://doi.org/10.1016/j.molcel.2020.08.006


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten, Lehrer/Schüler, Studierende, Wirtschaftsvertreter, Wissenschaftler, jedermann
    Biologie, Ernährung / Gesundheit / Pflege, Medizin
    überregional
    Forschungs- / Wissenstransfer, Wissenschaftliche Publikationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).